BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28636262)

  • 1. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H; Watanabe T; Isoyama K
    Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
    Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
    J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
    Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
    J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
    Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
    Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin response in nocturnal enuresis showing concentrated urine.
    Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
    Pediatr Int; 2020 Jun; 62(6):701-704. PubMed ID: 32065484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial response to intranasal desmopressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights.
    Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle C; Vansintjan P; Donckerwolcke R; Vande Walle J
    J Urol; 2007 Sep; 178(3 Pt 1):1048-51; discussion 1051-2. PubMed ID: 17632162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis.
    Abdovic S; Cuk M; Hizar I; Milosevic M; Jerkovic A; Saraga M
    Int Urol Nephrol; 2021 Aug; 53(8):1529-1534. PubMed ID: 33774753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Frequently recurring' nocturnal polyuria is predictive of response to desmopressin in monosymptomatic nocturnal enuresis in childhood.
    Marzuillo P; Marotta R; Guarino S; Fedele MC; Palladino F; Capalbo D; Della Vecchia N; Miraglia Del Giudice E; Polito C; La Manna A
    J Pediatr Urol; 2019 Apr; 15(2):166.e1-166.e7. PubMed ID: 30528650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
    De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
    J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
    Tauris LH; Kamperis K; Hagstroem S; Bower WF; Rittig S
    J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of urine osmolality and other easily detected parameters on the response to desmopressin in the management of monosymptomatic nocturnal enuresis in children.
    Sözübir S; Ergun G; Celik A; Ulman I; Avanoglu A
    Minerva Urol Nefrol; 2006 Jun; 58(2):207-12. PubMed ID: 16767075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does desmopressin withdrawal strategy affect relapse rates in monosymptomatic enuresis treatment?
    Issi Y; Biçakci U
    Eur J Pediatr; 2021 May; 180(5):1453-1457. PubMed ID: 33389072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
    Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
    BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agents in the management of paediatric monosymptomatic nocturnal enuresis: a network meta-analysis.
    Song P; Huang C; Wang Y; Wang Q; Zhu W; Yue Y; Wang W; Feng J; He X; Cui L; Wan T; Wen J
    BJU Int; 2019 Mar; 123(3):388-400. PubMed ID: 30216627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics.
    Dossche L; Michelet R; De Bruyne P; Van Herzeele C; Gasthuys E; Rittig S; Vermeulen A; Vande Walle J
    Arch Dis Child; 2021 Jun; 106(6):597-602. PubMed ID: 32737054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.